Jialiang Medical Secures Spot on Inaugural Forbes China's 100 Most Valuable Startups List and Files IPO Prospectus

Apr 10, 2025 08:06 CST Updated 08:06

GenLight

Innovative Medical Device Solution Provider

Joy

News

Recently, the results of the inaugural Forbes China Investment Value Start-up 100 Series were unveiled, and Genlight Neurotech stood out among numerous outstanding start-ups with its remarkable innovative achievements and immense development potential in the fields of brain science and neurosurgery, successfully making the list.

Since its establishment, Genlight Neurotech has been committed to becoming a trusted leader in innovative solutions within the field of neurology. Its successful inclusion in the inaugural Forbes China Top 100 Startups with Investment Value is not only a full recognition of the company’s technology, products, and market performance, but also the best reward for its development philosophy of upholding independent innovation and benefiting patients!

In the future, Genlight Neurotech will accelerate its pace of innovation, expand its industry influence, and contribute to human health!

About Genlight Neurotech

Genlight Neurotech was founded in Hangzhou in 2020 as a high-tech platform enterprise dedicated to industrializing cutting-edge technologies in the fields of brain science and neurosurgery.

The company has built three advanced technology platforms: brain-computer modulation, medical lasers, and brain-computer chips, providing innovative device solutions for various neurological disorders. Developed products include a magnetic resonance-guided laser ablation surgery system (LITT) for minimally invasive brain surgeries, an implantable closed-loop self-responsive neurostimulation system for treating epilepsy and Parkinson’s disease, and deep brain electrodes, some of which have entered the formal clinical trial stage.

Genlight Neurotech adheres to the concept of independent innovation and benefiting patients, with a global layout and coordinated development of production and research, striving to become a trusted leader in solutions within the field of neurology.